Linked Data API

Show Search Form

Search Results

386886
star this property registered interest false more like this
star this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Amyloidosis and Multiple Myeloma more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether they will place in the Library of the House any publications resulting from the phase 3 clinical trials approved for the potential treatment of systemic amyloidosis or multiple myeloma; and what is the National Institute of Health Research’s assessment of progress in these areas. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL995 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thisremove minimum value filter
unstar this property answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p>
star this property answering member printed Lord Prior of Brampton remove filter
star this property grouped question UIN
HL996 more like this
HL997 more like this
star this property question first answered
remove maximum value filtermore like thismore than 2015-07-14T15:34:29.197Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
unstar this property attachment
1
star this property file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf more like this
star this property title 2013-14 Annual Report more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
387225
star this property registered interest false more like this
star this property date less than 2015-07-02more like thismore than 2015-07-02
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Mental Health Services: Ethnic Groups more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what assessment they have made of the level of mental health resources and support currently available to young people from Black, Asian and Minority Ethnic backgrounds. more like this
star this property tabling member printed
Baroness Lawrence of Clarendon more like this
star this property uin HL1061 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thisremove minimum value filter
unstar this property answer text <p>The Department has not made an assessment of the level of mental health resources and support currently available to young people from Black, Asian and Minority Ethnic backgrounds. Commissioners and providers of NHS services are required to ensure that the services they commission or provide operate in such a way to meet the needs of diverse groups, including people from Black and Minority Ethnic communities.</p><p> </p><p> </p><p> </p><p>The Children and Young People’s Mental Health and Wellbeing Taskforce considered the mental health needs of all children and young people. As part of this work, a specific group was set up to look at the needs of vulnerable groups and inequalities. A report from this group was published alongside the <em>Future in mind</em> report.</p><p> </p><p> </p><p> </p><p>The Department is commissioning a new prevalence survey for children and young people’s mental health. We anticipate that the new survey will report on ethnicity, which would provide us with more up-to-date information on the mental health needs of children and young people from Black and Minority Ethnic groups.</p><p> </p><p> </p><p> </p><p>Difficulties may arise preventing access to mental health services by members of some communities due to the stigma attached to mental illness among those communities. We believe that Time to Change, a joint anti-stigma campaign led by Mind and Rethink, is addressing this issue and we are considering how best to help.</p><p> </p>
star this property answering member printed Lord Prior of Brampton remove filter
star this property grouped question UIN HL1064 more like this
star this property question first answered
less than 2015-07-14T15:22:56.573Zmore like thismore than 2015-07-14T15:22:56.573Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
4290
unstar this property label Biography information for Baroness Lawrence of Clarendon more like this
387226
star this property registered interest false more like this
star this property date less than 2015-07-02more like thismore than 2015-07-02
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Mental Health Services: Ethnic Groups more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether they intend to make additional resources available to mental health services in Black, Asian and Minority Ethnic communities, and if so, what resources they will make available. more like this
star this property tabling member printed
Baroness Lawrence of Clarendon more like this
star this property uin HL1062 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thisremove minimum value filter
unstar this property answer text <p>Everyone should be able to access mental health services according to need. However, we know that there are inequalities in the access to mental health services. For example, older adults, men, Black, Asian and Minority Ethnic (BAME) communities and those who are Deaf are not accessing services in the numbers predicted by prevalence studies. The National Health Service is leading on work on equality of access. We are listening to people with experience of mental health within BAME communities and continuing to make the changes needed to ensure equality throughout mental health services.</p><p> </p><p> </p><p> </p><p>There are no plans to make additional resources available for mental health services in BAME communities. However, planning requirements for 2015-2016 require clinical commissioning groups to invest additionally in mental health in line with the growth in their overall funding allocation, which should benefit all communities.</p><p> </p><p> </p><p> </p><p>In July 2014, the Joint Commissioning Panel for Mental Health published guidance for commissioners of mental health services for those from black and minority ethnic communities which is attached and can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.jcpmh.info/wp-content/uploads/jcpmh-bme-guide.pdf" target="_blank">http://www.jcpmh.info/wp-content/uploads/jcpmh-bme-guide.pdf</a></p><p> </p><p> </p><p> </p><p>The Department has been working with NHS England and commissioners to disseminate this guidance which describes what ‘good’ mental health services for people from BAME communities look like.</p><p> </p><p> </p><p> </p><p>One of the key priorities of the work in updating the <em>Mental Health Act 1983 Code of Practice</em>, which was published in January 2015, was to eliminate discrimination, including for people from BAME communities. The Department’s published Equality Analysis <em>Equality for all: Mental Health Act 1983: Code of Practice</em> sets out a range of additional guidance that has been included aiming to address concerns raised by BAME stakeholders and others.</p><p> </p>
star this property answering member printed Lord Prior of Brampton remove filter
star this property grouped question UIN
HL1063 more like this
HL1065 more like this
star this property question first answered
less than 2015-07-14T15:27:38.407Zmore like thismore than 2015-07-14T15:27:38.407Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
unstar this property attachment
1
star this property file name Joint Commissioning Panel for Mental Health BME Guidance.pdf more like this
star this property title Joint Commissioning Panel - Mental Health guidance more like this
star this property tabling member
4290
unstar this property label Biography information for Baroness Lawrence of Clarendon more like this
387227
star this property registered interest false more like this
star this property date less than 2015-07-02more like thismore than 2015-07-02
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Mental Health Services: Ethnic Groups more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what assessment they have made of early intervention and preventative mental health services and the extent to which these are used by Black, Asian and Minority Ethnic communities. more like this
star this property tabling member printed
Baroness Lawrence of Clarendon more like this
star this property uin HL1063 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thisremove minimum value filter
unstar this property answer text <p>Everyone should be able to access mental health services according to need. However, we know that there are inequalities in the access to mental health services. For example, older adults, men, Black, Asian and Minority Ethnic (BAME) communities and those who are Deaf are not accessing services in the numbers predicted by prevalence studies. The National Health Service is leading on work on equality of access. We are listening to people with experience of mental health within BAME communities and continuing to make the changes needed to ensure equality throughout mental health services.</p><p> </p><p> </p><p> </p><p>There are no plans to make additional resources available for mental health services in BAME communities. However, planning requirements for 2015-2016 require clinical commissioning groups to invest additionally in mental health in line with the growth in their overall funding allocation, which should benefit all communities.</p><p> </p><p> </p><p> </p><p>In July 2014, the Joint Commissioning Panel for Mental Health published guidance for commissioners of mental health services for those from black and minority ethnic communities which is attached and can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.jcpmh.info/wp-content/uploads/jcpmh-bme-guide.pdf" target="_blank">http://www.jcpmh.info/wp-content/uploads/jcpmh-bme-guide.pdf</a></p><p> </p><p> </p><p> </p><p>The Department has been working with NHS England and commissioners to disseminate this guidance which describes what ‘good’ mental health services for people from BAME communities look like.</p><p> </p><p> </p><p> </p><p>One of the key priorities of the work in updating the <em>Mental Health Act 1983 Code of Practice</em>, which was published in January 2015, was to eliminate discrimination, including for people from BAME communities. The Department’s published Equality Analysis <em>Equality for all: Mental Health Act 1983: Code of Practice</em> sets out a range of additional guidance that has been included aiming to address concerns raised by BAME stakeholders and others.</p><p> </p>
star this property answering member printed Lord Prior of Brampton remove filter
star this property grouped question UIN
HL1062 more like this
HL1065 more like this
star this property question first answered
less than 2015-07-14T15:27:38.5Zmore like thismore than 2015-07-14T15:27:38.5Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
unstar this property attachment
1
star this property file name Joint Commissioning Panel for Mental Health BME Guidance.pdf more like this
star this property title Joint Commissioning Panel - Mental Health guidance more like this
star this property tabling member
4290
unstar this property label Biography information for Baroness Lawrence of Clarendon more like this
387229
star this property registered interest false more like this
star this property date less than 2015-07-02more like thismore than 2015-07-02
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Mental Health Services: Ethnic Groups more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government, following the Ethnic Inequality and Mental Health Consultation by Lankelly Chase Foundation, what efforts they are making to address the dissatisfaction felt within the Black, Asian and Minority Ethnic mental health sector with the Government's lack of commitment to address ethnic inequalities in mental health. more like this
star this property tabling member printed
Baroness Lawrence of Clarendon more like this
star this property uin HL1065 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thisremove minimum value filter
unstar this property answer text <p>Everyone should be able to access mental health services according to need. However, we know that there are inequalities in the access to mental health services. For example, older adults, men, Black, Asian and Minority Ethnic (BAME) communities and those who are Deaf are not accessing services in the numbers predicted by prevalence studies. The National Health Service is leading on work on equality of access. We are listening to people with experience of mental health within BAME communities and continuing to make the changes needed to ensure equality throughout mental health services.</p><p> </p><p> </p><p> </p><p>There are no plans to make additional resources available for mental health services in BAME communities. However, planning requirements for 2015-2016 require clinical commissioning groups to invest additionally in mental health in line with the growth in their overall funding allocation, which should benefit all communities.</p><p> </p><p> </p><p> </p><p>In July 2014, the Joint Commissioning Panel for Mental Health published guidance for commissioners of mental health services for those from black and minority ethnic communities which is attached and can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.jcpmh.info/wp-content/uploads/jcpmh-bme-guide.pdf" target="_blank">http://www.jcpmh.info/wp-content/uploads/jcpmh-bme-guide.pdf</a></p><p> </p><p> </p><p> </p><p>The Department has been working with NHS England and commissioners to disseminate this guidance which describes what ‘good’ mental health services for people from BAME communities look like.</p><p> </p><p> </p><p> </p><p>One of the key priorities of the work in updating the <em>Mental Health Act 1983 Code of Practice</em>, which was published in January 2015, was to eliminate discrimination, including for people from BAME communities. The Department’s published Equality Analysis <em>Equality for all: Mental Health Act 1983: Code of Practice</em> sets out a range of additional guidance that has been included aiming to address concerns raised by BAME stakeholders and others.</p><p> </p>
star this property answering member printed Lord Prior of Brampton remove filter
star this property grouped question UIN
HL1062 more like this
HL1063 more like this
star this property question first answered
less than 2015-07-14T15:27:38.603Zmore like thismore than 2015-07-14T15:27:38.603Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
unstar this property attachment
1
star this property file name Joint Commissioning Panel for Mental Health BME Guidance.pdf more like this
star this property title Joint Commissioning Panel - Mental Health guidance more like this
star this property tabling member
4290
unstar this property label Biography information for Baroness Lawrence of Clarendon more like this
387228
star this property registered interest false more like this
star this property date less than 2015-07-02more like thismore than 2015-07-02
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Mental Health Services: Ethnic Groups more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what efforts they are making to address the lack of access to mental health services for young people from Black, Asian and Minority Ethnic communities. more like this
star this property tabling member printed
Baroness Lawrence of Clarendon more like this
star this property uin HL1064 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thisremove minimum value filter
unstar this property answer text <p>The Department has not made an assessment of the level of mental health resources and support currently available to young people from Black, Asian and Minority Ethnic backgrounds. Commissioners and providers of NHS services are required to ensure that the services they commission or provide operate in such a way to meet the needs of diverse groups, including people from Black and Minority Ethnic communities.</p><p> </p><p> </p><p> </p><p>The Children and Young People’s Mental Health and Wellbeing Taskforce considered the mental health needs of all children and young people. As part of this work, a specific group was set up to look at the needs of vulnerable groups and inequalities. A report from this group was published alongside the <em>Future in mind</em> report.</p><p> </p><p> </p><p> </p><p>The Department is commissioning a new prevalence survey for children and young people’s mental health. We anticipate that the new survey will report on ethnicity, which would provide us with more up-to-date information on the mental health needs of children and young people from Black and Minority Ethnic groups.</p><p> </p><p> </p><p> </p><p>Difficulties may arise preventing access to mental health services by members of some communities due to the stigma attached to mental illness among those communities. We believe that Time to Change, a joint anti-stigma campaign led by Mind and Rethink, is addressing this issue and we are considering how best to help.</p><p> </p>
star this property answering member printed Lord Prior of Brampton remove filter
star this property grouped question UIN HL1061 more like this
star this property question first answered
less than 2015-07-14T15:22:56.683Zmore like thismore than 2015-07-14T15:22:56.683Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
4290
unstar this property label Biography information for Baroness Lawrence of Clarendon more like this
386923
star this property registered interest false more like this
star this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Vitamin B12 more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what steps they are taking to find an alternative and reliable test to assess the vitamin B12 status of the population; and what level of false high results the current test provides. more like this
star this property tabling member printed
The Countess of Mar more like this
star this property uin HL1032 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thisremove minimum value filter
unstar this property answer text <p>The diagnosis and treatment of pernicious anaemia, the result of a vitamin B12 (cobalamin) deficiency, is well established and reported in the British Committee for Standards in Haematology (BCSH) guidance document, <em>Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders</em>, which was updated in May 2014. A copy of the BCSH guidance document is attached.</p><p> </p><p>The BCSH operates independently of the Department and NHS England and produces evidence based guidelines for both clinical and laboratory haematologists on the diagnosis and treatment of haematological disease, drawing on the advice of expert consultants and clinical scientists practicing in the United Kingdom. It would be for the BCSH, not the Department, to consider whether any adjustments to current best practice, in the diagnosis and treatment of patients with pernicious anaemia were needed, including whether any new or additional tests were appropriate.</p><p> </p><p> </p><p> </p><p>The BCSH guidance sets out that cobalamin status is the recommended first line diagnostic test. The Department has no data relating to false positive results in relation to the test. The guidance also states that clinical picture is the most important factor in assessing the significance of the test results.</p><p> </p><p> </p><p> </p><p>When anaemia is diagnosed, most patients respond well to treatment through quarterly intramuscular injection of vitamin B12. Whilst some patients with pernicious anaemia might prefer to have more frequent injections, or for other forms of vitamin B12 to be self-administered, these are matters for individual patients to discuss with their general practitioners.</p><p> </p><p> </p><p> </p><p>Although the Medicines Healthcare products Regulatory Agency is currently reviewing claims made by some clinics that are administering vitamins and minerals intravenously for nutritional therapy purposes, the agency has not encountered any clinics making claims to treat pernicious anaemia. In addition, the Department does not have any information regarding patients purchasing additional supplies of B12 from unregulated sources.</p><p> </p><p> </p><p> </p><p>Regarding the mandatory fortification of flour with folic acid, the Scientific Advisory Committee on Nutrition recommended a number of measures to ensure monitoring and surveillance of the impact of fortification of flour, should it be implemented. This included appropriate systems to monitor any potential adverse effects, including cancer and a review of the evidence on benefits and postulated risks after five years. The National Diet and Nutrition Survey monitors folate intakes and the most recent data, which was published earlier this year, will be carefully considered alongside other information sources before any decision is made on mandatory fortification.</p><p> </p><p> </p><p> </p><p>The Department has made no assessment of the social and economic costs of misdiagnosis or late diagnosis of pernicious anaemia and other vitamin B12 deficiencies.</p><p> </p>
star this property answering member printed Lord Prior of Brampton remove filter
star this property grouped question UIN
HL1033 more like this
HL1034 more like this
HL1035 more like this
HL1036 more like this
HL1042 more like this
star this property question first answered
less than 2015-07-14T15:00:41.673Zmore like thismore than 2015-07-14T15:00:41.673Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
unstar this property attachment
1
star this property file name colbalamin and folate disorders.pdf more like this
star this property title BSCH Guidance more like this
star this property tabling member
1861
unstar this property label Biography information for The Countess of Mar more like this
386924
star this property registered interest false more like this
star this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Vitamin B12 more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether they plan to review how pernicious anaemia and other symptoms of vitamin B12 deficiency in the United Kingdom population are diagnosed and treated, particularly taking into account the neurological and mental health impact of any failure to diagnose quickly and accurately; and, if not, why not. more like this
star this property tabling member printed
The Countess of Mar more like this
star this property uin HL1033 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thisremove minimum value filter
unstar this property answer text <p>The diagnosis and treatment of pernicious anaemia, the result of a vitamin B12 (cobalamin) deficiency, is well established and reported in the British Committee for Standards in Haematology (BCSH) guidance document, <em>Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders</em>, which was updated in May 2014. A copy of the BCSH guidance document is attached.</p><p> </p><p>The BCSH operates independently of the Department and NHS England and produces evidence based guidelines for both clinical and laboratory haematologists on the diagnosis and treatment of haematological disease, drawing on the advice of expert consultants and clinical scientists practicing in the United Kingdom. It would be for the BCSH, not the Department, to consider whether any adjustments to current best practice, in the diagnosis and treatment of patients with pernicious anaemia were needed, including whether any new or additional tests were appropriate.</p><p> </p><p> </p><p> </p><p>The BCSH guidance sets out that cobalamin status is the recommended first line diagnostic test. The Department has no data relating to false positive results in relation to the test. The guidance also states that clinical picture is the most important factor in assessing the significance of the test results.</p><p> </p><p> </p><p> </p><p>When anaemia is diagnosed, most patients respond well to treatment through quarterly intramuscular injection of vitamin B12. Whilst some patients with pernicious anaemia might prefer to have more frequent injections, or for other forms of vitamin B12 to be self-administered, these are matters for individual patients to discuss with their general practitioners.</p><p> </p><p> </p><p> </p><p>Although the Medicines Healthcare products Regulatory Agency is currently reviewing claims made by some clinics that are administering vitamins and minerals intravenously for nutritional therapy purposes, the agency has not encountered any clinics making claims to treat pernicious anaemia. In addition, the Department does not have any information regarding patients purchasing additional supplies of B12 from unregulated sources.</p><p> </p><p> </p><p> </p><p>Regarding the mandatory fortification of flour with folic acid, the Scientific Advisory Committee on Nutrition recommended a number of measures to ensure monitoring and surveillance of the impact of fortification of flour, should it be implemented. This included appropriate systems to monitor any potential adverse effects, including cancer and a review of the evidence on benefits and postulated risks after five years. The National Diet and Nutrition Survey monitors folate intakes and the most recent data, which was published earlier this year, will be carefully considered alongside other information sources before any decision is made on mandatory fortification.</p><p> </p><p> </p><p> </p><p>The Department has made no assessment of the social and economic costs of misdiagnosis or late diagnosis of pernicious anaemia and other vitamin B12 deficiencies.</p><p> </p>
star this property answering member printed Lord Prior of Brampton remove filter
star this property grouped question UIN
HL1032 more like this
HL1034 more like this
HL1035 more like this
HL1036 more like this
HL1042 more like this
star this property question first answered
less than 2015-07-14T15:00:41.81Zmore like thismore than 2015-07-14T15:00:41.81Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
unstar this property attachment
1
star this property file name colbalamin and folate disorders.pdf more like this
star this property title BSCH Guidance more like this
star this property tabling member
1861
unstar this property label Biography information for The Countess of Mar more like this
386925
star this property registered interest false more like this
star this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Vitamin B12 more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what steps they are taking to ensure that a reliable test to assess the vitamin B12 status of the United Kingdom population is made available as a means to prevent serious and irreversible neurological damage before any mandatory fortification of flour with folic acid is introduced. more like this
star this property tabling member printed
The Countess of Mar more like this
star this property uin HL1034 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thisremove minimum value filter
unstar this property answer text <p>The diagnosis and treatment of pernicious anaemia, the result of a vitamin B12 (cobalamin) deficiency, is well established and reported in the British Committee for Standards in Haematology (BCSH) guidance document, <em>Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders</em>, which was updated in May 2014. A copy of the BCSH guidance document is attached.</p><p> </p><p>The BCSH operates independently of the Department and NHS England and produces evidence based guidelines for both clinical and laboratory haematologists on the diagnosis and treatment of haematological disease, drawing on the advice of expert consultants and clinical scientists practicing in the United Kingdom. It would be for the BCSH, not the Department, to consider whether any adjustments to current best practice, in the diagnosis and treatment of patients with pernicious anaemia were needed, including whether any new or additional tests were appropriate.</p><p> </p><p> </p><p> </p><p>The BCSH guidance sets out that cobalamin status is the recommended first line diagnostic test. The Department has no data relating to false positive results in relation to the test. The guidance also states that clinical picture is the most important factor in assessing the significance of the test results.</p><p> </p><p> </p><p> </p><p>When anaemia is diagnosed, most patients respond well to treatment through quarterly intramuscular injection of vitamin B12. Whilst some patients with pernicious anaemia might prefer to have more frequent injections, or for other forms of vitamin B12 to be self-administered, these are matters for individual patients to discuss with their general practitioners.</p><p> </p><p> </p><p> </p><p>Although the Medicines Healthcare products Regulatory Agency is currently reviewing claims made by some clinics that are administering vitamins and minerals intravenously for nutritional therapy purposes, the agency has not encountered any clinics making claims to treat pernicious anaemia. In addition, the Department does not have any information regarding patients purchasing additional supplies of B12 from unregulated sources.</p><p> </p><p> </p><p> </p><p>Regarding the mandatory fortification of flour with folic acid, the Scientific Advisory Committee on Nutrition recommended a number of measures to ensure monitoring and surveillance of the impact of fortification of flour, should it be implemented. This included appropriate systems to monitor any potential adverse effects, including cancer and a review of the evidence on benefits and postulated risks after five years. The National Diet and Nutrition Survey monitors folate intakes and the most recent data, which was published earlier this year, will be carefully considered alongside other information sources before any decision is made on mandatory fortification.</p><p> </p><p> </p><p> </p><p>The Department has made no assessment of the social and economic costs of misdiagnosis or late diagnosis of pernicious anaemia and other vitamin B12 deficiencies.</p><p> </p>
star this property answering member printed Lord Prior of Brampton remove filter
star this property grouped question UIN
HL1032 more like this
HL1033 more like this
HL1035 more like this
HL1036 more like this
HL1042 more like this
star this property question first answered
less than 2015-07-14T15:00:41.947Zmore like thismore than 2015-07-14T15:00:41.947Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
unstar this property attachment
1
star this property file name colbalamin and folate disorders.pdf more like this
star this property title BSCH Guidance more like this
star this property tabling member
1861
unstar this property label Biography information for The Countess of Mar more like this
386926
star this property registered interest false more like this
star this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Vitamin B12 more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what assessment they have made of the frequency at which patients with pernicious anaemia require vitamin B12 replacement therapy by injection; whether they have any evidence that patients are purchasing additional supplies from unregulated sources; and whether they will review current guidance. more like this
star this property tabling member printed
The Countess of Mar more like this
star this property uin HL1035 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thisremove minimum value filter
unstar this property answer text <p>The diagnosis and treatment of pernicious anaemia, the result of a vitamin B12 (cobalamin) deficiency, is well established and reported in the British Committee for Standards in Haematology (BCSH) guidance document, <em>Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders</em>, which was updated in May 2014. A copy of the BCSH guidance document is attached.</p><p> </p><p>The BCSH operates independently of the Department and NHS England and produces evidence based guidelines for both clinical and laboratory haematologists on the diagnosis and treatment of haematological disease, drawing on the advice of expert consultants and clinical scientists practicing in the United Kingdom. It would be for the BCSH, not the Department, to consider whether any adjustments to current best practice, in the diagnosis and treatment of patients with pernicious anaemia were needed, including whether any new or additional tests were appropriate.</p><p> </p><p> </p><p> </p><p>The BCSH guidance sets out that cobalamin status is the recommended first line diagnostic test. The Department has no data relating to false positive results in relation to the test. The guidance also states that clinical picture is the most important factor in assessing the significance of the test results.</p><p> </p><p> </p><p> </p><p>When anaemia is diagnosed, most patients respond well to treatment through quarterly intramuscular injection of vitamin B12. Whilst some patients with pernicious anaemia might prefer to have more frequent injections, or for other forms of vitamin B12 to be self-administered, these are matters for individual patients to discuss with their general practitioners.</p><p> </p><p> </p><p> </p><p>Although the Medicines Healthcare products Regulatory Agency is currently reviewing claims made by some clinics that are administering vitamins and minerals intravenously for nutritional therapy purposes, the agency has not encountered any clinics making claims to treat pernicious anaemia. In addition, the Department does not have any information regarding patients purchasing additional supplies of B12 from unregulated sources.</p><p> </p><p> </p><p> </p><p>Regarding the mandatory fortification of flour with folic acid, the Scientific Advisory Committee on Nutrition recommended a number of measures to ensure monitoring and surveillance of the impact of fortification of flour, should it be implemented. This included appropriate systems to monitor any potential adverse effects, including cancer and a review of the evidence on benefits and postulated risks after five years. The National Diet and Nutrition Survey monitors folate intakes and the most recent data, which was published earlier this year, will be carefully considered alongside other information sources before any decision is made on mandatory fortification.</p><p> </p><p> </p><p> </p><p>The Department has made no assessment of the social and economic costs of misdiagnosis or late diagnosis of pernicious anaemia and other vitamin B12 deficiencies.</p><p> </p>
star this property answering member printed Lord Prior of Brampton remove filter
star this property grouped question UIN
HL1032 more like this
HL1033 more like this
HL1034 more like this
HL1036 more like this
HL1042 more like this
star this property question first answered
less than 2015-07-14T15:00:42.073Zmore like thismore than 2015-07-14T15:00:42.073Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
unstar this property attachment
1
star this property file name colbalamin and folate disorders.pdf more like this
star this property title BSCH Guidance more like this
star this property tabling member
1861
unstar this property label Biography information for The Countess of Mar more like this